Skip to main content
×
Home
    • Aa
    • Aa

Trypanosomiasis and the brain

  • JEAN RODGERS (a1)
Summary
SUMMARY

Neurological involvement following trypanosome infection has been recognised for over a century. However, there are still many unanswered questions concerning the mechanisms used by the parasite to gain entry to the CNS and the pathogenesis of the resulting neuroinflammatory reaction. There is a paucity of material from human cases of the disease therefore the majority of current research relies on the use of animal models of trypanosome infection. This review reports contemporary knowledge, from both animal models and human samples, regarding parasite invasion of the CNS and the neuropathological changes that accompany trypanosome infection and disease progression. The effects of trypanosomes on the blood-brain barrier are discussed and possible key molecules in parasite penetration of the barrier highlighted. Changes in the balance of CNS cytokines and chemokines are also described. The article closes by summarising the effects of trypanosome infection on the circadian sleep-wake cycle, and sleep structure, in relation to neuroinflammation and parasite location within the CNS. Although a great deal of progress has been made in recent years, the advent and application of sophisticated analysis techniques, to decipher the complexities of HAT pathogenesis, herald an exciting and rewarding period for advances in trypanosome research.

Copyright
Corresponding author
*Tel.: +44 101 330 3797. Fax: +44 141 330 5603. Email: Jean.Rodgers@vet.gla.ac.uk
References
Hide All
Abbott N. J., Ronnback L. and Hansson E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews in Neuroscience 7, 4153.
Abdulla M. H., O'Brien T., Mackey Z. B., Sajid M., Grab D. J. and McKerrow J. H. (2008). RNA Interference of Trypanosoma brucei Cathepsin B and L affects disease progression in a mouse model. PLoS Neglected Tropical Diseases 2, e298.
Adams J. H. and Graham D. I. (1998). Virus and other infections. In An introduction to Neuropathology (ed. Adams J. H. and Graham D. I.), pp. 94–117. Churchhill Livingstone, Edinburgh.
Adams J. H., Haller L., Boa F. Y., Doua F., Dago A. and Konian K. (1986). Human African trypanosomiasis (T. b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathology and Applied Neurobiology 12, 8194.
Amin D. N., Masocha W., Ngan'dwe K., Rottenberg M. and Kristensson K. (2008). Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion. Acta Tropica 106, 7274.
Anthoons J. A. M. S., Van Marck E. A. E., Gigase P. L. J. and Stevens W. J. (1989). Immunohistochemical characterization of the mononuclear cells in the brain of the rat with experimental chronic Trypanosoma brucei gambiense infection. Parasitology Research 75, 251256.
Apted F. I. C. (1970). Clinical manifestations and diagnosis of sleeping sickness. In The African Trypanosomiases (ed. Mulligan H. W.), pp. 661683. Allen & Urwin, London.
Atouguia J. L. M. and Kennedy P. G. E. (2000). Neurological aspects of human African trypanosomiasis. In Infectious Diseases of the Nervous System (ed. Davies Larry E. and Kennedy Peter G. E.), pp. 321372. Butterworth-Heinemann, Oxford.
Barrett M. P., Boykin D. W., Brun R. and Tidwell R. R. (2007). Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. British Journal of Pharmacology 152, 11551171.
Bentivoglio M., Grassi-Zucconi G., Olsson T. and Kristensson K. (1994). Trypanosoma brucei and the nervous system. Trends in Neuroscience 17, 325329.
Bentivoglio M. and Kristensson K. (2007). Neural-immune interactions in disorders of sleep-wakefulness organization. Trends in Neuroscience 30, 645652.
Braakman H. M., van de Molengraft F. J., Hubert W. W. and Boerman D. H. (2006). Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66, 10941096.
Buguet A., Bisser S., Josenando T., Chapotot F. and Cespuglio R. (2005). Sleep structure: a new diagnostic tool for stage determination in sleeping sickness. Acta Tropica 93, 107117.
Buguet A., Bourdon L., Bouteille B., Cespuglio R., Vincendeau P., Radomski M. W. and Dumas M. (2001). The duality of sleeping sickness: focusing on sleep. Sleep Medicine Reviews 5, 139153.
Calwell H. (1937). The pathology of the brain in Rhodesian trypanosomiasis. Transactions of the Royal Society of Tropical Medical and Hygiene 30, 611624.
Checkley A. M., Pepin J., Gibson W. C., Taylor M. N., Jager H. R. and Mabey D. C. (2007). Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy. Transactions of the Royal Society of Tropical Medical and Hygiene 101, 523526.
Chianella S., Semprevivo M., Peng Z. C., Zaccheo D., Bentivoglio M. and Grassi-Zucconi G. (1999). Microglia activation in a model of sleep disorder: an immunohistochemical study in the rat brain during Trypanosoma brucei infection. Brain Research 832, 5462.
Coogan A. N. and Wyse C. A. (2008). Neuroimmunology of the circadian clock. Brain Research 1232, 104112.
Courtioux B., Boda C., Vatunga G., Pervieux L., Josenando T., M'Eyi P. M., Bouteille B., Jauberteau-Marchan M. O. and Bisser S. (2006). A link between chemokine levels and disease severity in human African trypanosomiasis. International Journal for Parasitology 36, 10571065.
Doua F., Miezan T. W., Sanon S. Jr., Boa Y. F. and Baltz T. (1996). The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. American Journal of Tropical Medicine and Hygiene 55, 586588.
Fink E. and Schmidt H. (1979). Meningoencephalitis in chronic Trypanosoma brucei rhodesiense infection of the white mouse. Tropenmedizin und Parasitologie 30, 206211.
Gill D. S., Chatha D. S. and Carpio-O'Donovan R. (2003). MR imaging findings in African trypansomiasis. American Journal of Neuroradiology 24, 13831385.
Grab D. J. and Kennedy P. G. (2008). Traversal of human and animal trypanosomes across the blood-brain barrier. Journal of NeuroVirology 14, 344351.
Grab D. J., Nikolskaia O., Kim Y. V., Lonsdale-Eccles J. D., Ito S., Hara T., Fukuma T., Nyarko E., Kim K. J., Stins M. F., Delannoy M. J., Rodgers J. and Kim K. S. (2004). African trypanosome interactions with an in vitro model of the human blood-brain barrier. Journal of Parasitology 90, 970979.
Grassi-Zucconi G., Harris J. A., Mohammed A. H., Ambrosini M. V., Kristensson K. and Bentivoglio M. (1995). Sleep fragmentation, and changes in locomotor activity and body temperature in trypanosome-infected rats. Brain Research Bulletin 37, 123129.
Grassi-Zucconi G., Semprevivo M., Mocaer E., Kristensson K. and Bentivoglio M. (1996). Melatonin and its new agonist S-20098 restore synchronized sleep fragmented by experimental trypanosome infection in the rat. Brain Research Bulletin 39, 6368.
Hawkins B. T. and Davis T. P. (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacological Reviews 57, 173185.
Hunter C. A., Gow J. W., Kennedy P. G., Jennings F. W. and Murray M. (1991). Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice. Infection and Immunity 59, 46364640.
Hunter C. A., Jennings F. W., Adams J. H., Murray M. and Kennedy P. G. (1992 a). Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis. Lancet 339, 956958.
Hunter C. A., Jennings F. W., Kennedy P. G. and Murray M. (1992 b). Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. Laboratory Investigation 67, 635642.
Hunter C. A. and Kennedy P. G. (1992). Immunopathology in central nervous system human African trypanosomiasis. Journal of Neuroimmunology 36, 9195.
Jennings F. W., Gichuki C. W., Kennedy P. G., Rodgers J., Hunter C. A., Murray M. and Burke J. M. (1997). The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis. Neuropathology and Applied Neurobiology 23, 225234.
Johansson P. A., Dziegielewska K. M., Liddelow S. A. and Saunders N. R. (2008). The blood-CSF barrier explained: when development is not immaturity. Bioessays 30, 237248.
Kennedy P. G. (1999). The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis. Journal of Neuroimmunology 100, 3641.
Kennedy P. G. (2004). Human African trypanosomiasis of the CNS: current issues and challenges. Journal of Clinical Investigation 113, 496504.
Kennedy P. G. (2006). Diagnostic and neuropathogenesis issues in human African trypanosomiasis. International Journal for Parasitology 36, 505512.
Kennedy P. G., Rodgers J., Bradley B., Hunt S. P., Gettinby G., Leeman S. E., de Felipe C. and Murray M. (2003). Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice. Brain 126, 16831690.
Kennedy P. G., Rodgers J., Jennings F. W., Murray M., Leeman S. E. and Burke J. M. (1997). A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proceedings of the National Academy of Sciences, USA 94, 41674170.
Krueger J. M., Obal F. J., Fang J., Kubota T. and Taishi P. (2001). The role of cytokines in physiological sleep regulation. Annals of New York Academy of Sciences 933, 211221.
Lejon V., Lardon J., Kenis G., Pinoges L., Legros D., Bisser S., N'Siesi X., Bosmans E. and Buscher P. (2002). Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Transactions of the Royal Society of Tropical Medical and Hygiene 96, 329333.
Lejon V., Legros D., Savignoni A., Etchegorry M. G., Mbulamberi D. and Buscher P. (2003 a). Neuro-inflammatory risk factors for treatment failure in “early second stage” sleeping sickness patients treated with pentamidine. Journal of Neuroimmunology 144, 132138.
Lejon V., Reiber H., Legros D., Dje N., Magnus E., Wouters I., Sindic C. J. and Buscher P. (2003 b). Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. Journal of Infectious Diseases 187, 14751483.
Lundkvist G. B., Christenson J., ElTayeb R. A. K., Peng Z.-C., Grillner P., Mhlanga J., Bentivoglio M. and Kristensson K. (1998 a). Altered neuronal activity rhythm and glutamate receptor expression in the suprachiasmatic nuclei of Trypanosoma brucei infected rats. Journal of Neuropathology and Experimental Neurology 57, 2129.
Lundkvist G. B., Hill R. H. and Kristensson K. (2002). Disruption of circadian rhythms in synaptic activity of the suprachiasmatic nuclei by African trypanosomes and cytokines. Neurobiology of Disease 11, 2027.
Lundkvist G. B., Kristensson K. and Bentivoglio M. (2004). Why trypanosomes cause sleeping sickness. Physiology (Bethesda) 19, 198206.
Lundkvist G. B., Robertson B., Mhlanga D. M., Rottenberg M. E. and Kristensson K. (1998 b). Expression of an oscillating interferon-gamma receptor in the suprachiasmstic nuclei. NeuroReport 9, 10591063.
MacLean L., Odiit M., MacLeod A., Morrison L., Sweeney L., Cooper A., Kennedy P. G. and Sternberg J. M. (2007). Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. Journal of Infectious Diseases 196, 16201628.
MacLean L., Odiit M. and Sternberg J. M. (2001). Nitric oxide and cytokine synthesis in human African trypanosomiasis. Journal of Infectious Diseases 184, 10861090.
MacLean L., Odiit M., and Sternberg J. M. (2006). Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients. Transactions of the Royal Society of Tropical Medical and Hygiene 100, 270275.
Man S., Ubogu E. E. and Ransohoff R. M. (2007). Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathology 17, 243250.
Masocha W., Robertson B., Rottenberg M. E., Mhlanga J., Sorokin L. and Kristensson K. (2004). Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. Journal of Clinical Investigation 114, 689694.
Masocha W., Rottenberg M. E. and Kristensson K. (2006). Minocycline impedes African trypanosome invasion of the brain in a murine model. Antimicrobial Agents and Chemotherapy 50, 17981804.
Masocha W., Rottenberg M. E., and Kristensson K. (2007). Migration of African trypanosomes across the blood-brain barrier. Physiology and Behavior 92, 110114.
McCarley R. W. (2007). Neurobiology of REM and NREM sleep. Sleep Medicine 8, 302330.
Montmayeur A., Brosset C., Imbert P. and Buguet A. (1994). [The sleep-wake cycle during Trypanosoma brucei rhodesiense human African trypanosomiasis in 2 French parachutists]. Bulletin de la Societe de Pathologie Exotique 87, 368371.
Mott F. W. (1907). Histological observations on the changes in the nervous system in trypanosome infections especially sleeping sickness and their relation to syphilitic lesions of the nervous system. Archives of Neurology 3, 581646.
Mulenga C., Mhlanga J. D., Kristensson K. and Robertson B. (2001). Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathology and Applied Neurobiology 27, 7785.
Nikolskaia O. V., de A. Lima A. P., Kim Y. V., Lonsdale-Eccles J. D., Fukuma T., Scharfstein J. and Grab D. J. (2006 a). Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease. Journal of Clinical Investigation 116, 27392747.
Nikolskaia O. V., de A. Lima A. P., Kim Y. V., Lonsdale-Eccles J. D., Fukuma T., Scharfstein J. and Grab D. J. (2008). Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease (corrigendum). Journal of Clinical Investigation 118, 1974.
Nikolskaia O. V., Kim Y. V., Kovbasnjuk O., Kim K. J. and Grab D. J. (2006 b). Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier. International Journal for Parasitology 36, 513519.
Obal F. Jr. and Krueger J. M. (2003). Biochemical regulation of non-rapid-eye-movement sleep. Frontiers in Bioscience 8, d520d550.
Opp M. R. (2005). Cytokines and sleep. Sleep Medicine Reviews 9, 355364.
Ouwe-Missi-Oukem-Boyer O., Mezui-Me-Ndong J., Boda C., Lamine I., Labrousse F., Bisser S. and Bouteille B. (2006). The vervet monkey (Chlorocebus aethiops) as an experimental model for Trypanosoma brucei gambiense human African trypanosomiasis: a clinical, biological and pathological study. Transactions of the Royal Society of Tropical Medical and Hygiene 100, 427436.
Peng Z. C., Kristensson K. and Bentivoglio M. (1994). Dysregulation of photic induction of Fos-related protein in the biological clock during experimental trypanosomiasis. Neuroscience Letters 182, 104106.
Pentreath V. W., Baugh P. J. and Lavin D. R. (1994). Sleeping sickness and the central nervous system. Onderstepoort Journal of Veterinary Research 6, 369377.
Pentreath V. W. (1989). Neurobiology of sleeping sickness. Parasitology Today 5, 215218.
Pepin J. and Milord F. (1994). The treatment of human African trypanosomiasis. Advances in Parasitology 33, 147.
Philip K. A., Dascombe M. J., Fraser P. A. and Pentreath V. W. (1994). Blood-brain barrier damage in experimental African trypanosomiasis. Annals of Tropical Medicine and Parasitology 88, 607616.
Poltera A. A., Hochmann A., Rudin W. and Lambert P. H. (1980). Trypanosoma brucei brucei: a model for cerebral trypanosomiasis in mice – an immunological, histological and electronmicroscopic study. Clinical and Experimental Immunology 40, 496507.
Poltera A. A., Sayer P. D., Brighouse G., Bovell D. and Rudin W. (1985). Immunopathological aspects of trypanosomal meningoencephalitis in vervet monkeys after relapse following Berenil treatment. Transactions of the Royal Society of Tropical Medical and Hygiene 79, 527531.
Quan N., He L. and Lai W. (2003). Intraventricular infusion of antagonists of IL-1 and TNF alpha attenuates neurodegeneration induced by the infection of Trypanosoma brucei. Journal of Neuroimmunology 138, 9298.
Quan N., Mhlanga J. D., Whiteside M. B., McCoy A. N., Kristensson K. and Herkenham M. (1999). Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei. Journal of Comparative Neurology 414, 114130.
Radomski M. W., Buguet A., Bogui P., Doua F., Lonsdorfer A., Tapie P. and Dumas M. (1994). Disruptions in the secretion of cortisol, prolactin, and certain cytokines in human African trypanosomiasis patients. Bulletin de la Societe de Pathologie Exotique 87, 376379.
Rodgers J., Bradley B. and Kennedy P. G. (2007). Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis. Parasitology International 56, 321324.
Rodgers J., Stone T., Barrett M. P., Bradley B. and Kennedy P. G. E. (2009). Kynurenine pathway inhibition reduces CNS inflammation in a model of human African trypanosomiasis. Brain 132, 12591267.
Sabbah P., Brosset C., Imbert P., Bonardel G., Jeandel P. and Briant J. F. (1997). Human African trypanosomiasis: MRI. Neuroradiology 39, 708710.
Sajid M. and McKerrow J. H. (2002). Cysteine proteases of parasitic organisms. Molecular and Biochemical Parasitology 120, 121.
Saunders N. R., Ek C. J., Habgood M. D. and Dziegielewska K. M. (2008). Barriers in the brain: a renaissance? Trends in Neuroscience 31, 279286.
Schmidt H. (1983). The pathogenesis of trypanosomiasis of the CNS. Studies on parasitological and neurohistological findings in trypanosoma rhodesiense infected vervet monkeys. Virchows Archiv A – Pathological Anatomy and Histopathology 399, 333343.
Schmidt H. and Sayer P. (1982). Trypanosoma brucei rhodesiense infection in vervet monkeys. I. Parasitologic, histologic, immunologic and histologic results. Tropenmedizin und Parasitologie 33, 249254.
Schultzberg M., Ambatsis M., Samuelsson E. B., Kristensson K. and Van Meirvenne N. (1988). Spread of Trypanosoma brucei to the nervous system: early attack on circumventricular organs and sensory ganglia. Journal of Neuroscience Research 21, 5661.
Sharafeldin A., Eltayeb R., Pashenkov M. and Bakhiet M. (2000). Chemokines are produced in the brain early during the course of experimental African trypanosomiasis. Journal of Neuroimmunology 103, 165170.
Sharafeldin A., Hamadien M., Diab A., Li H., Shi F. and Bakhiet M. (1999). Cytokine profiles in the central nervous system and the spleen during the early course of experimental African trypanosomiasis. Scandanavian Journal of Immunology 50, 256261.
Sixt M., Engelhardt B., Pausch F., Hallmann R., Wendler O. and Sorokin L. M. (2001). Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. Journal of Cell Biology 153, 933946.
Sternberg J. M., Rodgers J., Bradley B., MacLean L., Murray M. and Kennedy P. G. (2005). Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. Journal of Neuroimmunology 167, 8189.
Toth L. A., Tolley E. A., Broady R., Blakely B. and Krueger J. M. (1994). Sleep during experimental trypanosomiasis in rabbits. Proceedings of the Society for Experimental Biology and Medicine 205, 174181.
WHO (1998). Control and surveillance of African trypanosomiaisis. WHO technical report series, Geneva 881, 1113.
Zlokovic B. V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178201.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Parasitology
  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 6
Total number of PDF views: 46 *
Loading metrics...

Abstract views

Total abstract views: 235 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.